CARISMA THERAPEUTICS INC.

Profile

Company Names

CARISMA THERAPEUTICS INC.
CARMA THERAPEUTICS INC.

Addresses

3675 MARKET STREET, SUITE 200, PHILADELPHIA, PA 19104

3025 MARKET STREET, SUITE 140, PHILADELPHIA, PA 19104

3401 GRAYS FERRY AVENUE, BUILDING 212-151, PHILADELPHIA, PA 19146

Phone Numbers

484-899-0326
215-573-4504

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2017

State Incorporated:

DELAWARE

Total Amount Raised:

$95,046,400.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2020-12-22 
$38,269,452.00 
$70,352,521.00 
$32,083,069.00 
Equity 
2
2018-06-26 
$52,924,976.00 
$52,924,976.00 
$0.00 
Equity 
1
2017-05-31 
$3,851,972.00 
$3,851,972.00 
$0.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MARGARITA 
 
CHAVEZ 
DIRECTOR
CARMA THERAPEUTICS INC.   |  CARISMA THERAPEUTICS INC.   |  MAGNOLIA NEUROSCIENCES CORP   |  RODEO THERAPEUTICS CORP   |  NITROME BIOSCIENCES, INC   |  AMBAGON THERAPEUTICS INC.   |  SNC THERAPEUTICS, INC.   |  ALIGOS THERAPEUTICS, INC.
JACOB 
 
GUNTERBERG 
DIRECTOR
HEALTHCAP VI, L.P.   |  CARISMA THERAPEUTICS INC.
MICHAEL 
 
HEFFERNAN 
DIRECTOR
COLLEGIUM PHARMACEUTICAL INC   |  PRECISION DERMATOLOGY, INC.   |  CORNERSTONE THERAPEUTICS INC   |  GENOME ID GROUP, LLC   |  COLLEGIUM PHARMACEUTICAL, INC   |  EMIND SCIENCE CORP   |  TREVI THERAPEUTICS, INC.   |  CARISMA THERAPEUTICS INC.   |  PAR HEALTH, INC.
REGINA 
 
HODITS 
DIRECTOR
JENAVALVE TECHNOLOGY INC   |  CARISMA THERAPEUTICS INC.
STEVEN 
 
KELLY 
EXECUTIVE OFFICER, DIRECTOR
ARCH THERAPEUTICS, INC.   |  PINTEON THERAPEUTICS, INC.   |  ARTELO BIOSCIENCES, INC.   |  CARMA THERAPEUTICS INC.   |  CARISMA THERAPEUTICS INC.   |  BETTER LIFE PARTNERS INC.   |  BETTER LIFE PARTNERS INC.
HY 
 
LEVITSKY 
DIRECTOR
CARISMA THERAPEUTICS INC.
DORA 
 
MITCHELL 
DIRECTOR
CARMA THERAPEUTICS INC.   |  INTERIUS BIOTHERAPEUTICS, INC.
BRIGGS 
 
MORRISON 
DIRECTOR
ONCORUS, INC.   |  RIFT BIOTHERAPEUTICS, INC.   |  TWENTYEIGHT-SEVEN, INC.   |  ARVINAS, INC.   |  WEREWOLF THERAPEUTICS, INC.   |  CARISMA THERAPEUTICS INC.   |  CROSSBOW THERAPEUTICS, INC.   |  REUNION NEUROSCIENCE MANAGEMENT, INC.   |  CHARM THERAPEUTICS INC.
ERAN 
 
NADAV 
DIRECTOR
ULTRAGENYX PHARMACEUTICAL INC.   |  TREVI THERAPEUTICS, INC.   |  NOVASOM, INC   |  COLLEGIUM PHARMACEUTICAL, INC   |  CARISMA THERAPEUTICS INC.
BRUCE 
 
PEACOCK 
EXECUTIVE OFFICER, DIRECTOR
IKANO THERAPEUTICS INC.   |  OPHTHOTECH CORP.   |  INVISIBLE SENTINEL, INC.   |  PANOPTICA, INC.   |  CARMA THERAPEUTICS INC.   |  CARISMA THERAPEUTICS INC.   |  ARO BIOTHERAPEUTICS CO   |  WINDTREE THERAPEUTICS INC /DE/   |  INTERIUS BIOTHERAPEUTICS, INC.   |  VITTORIA BIOTHERAPEUTICS, INC.
MICHAEL 
 
POISEL 
DIRECTOR
CHIP DIAGNOSTICS, INC.   |  EXCALIVIR, INC.   |  CARMA THERAPEUTICS INC.   |  ENACHIP, INC.   |  LINNAEUS THERAPEUTICS, INC.
ALTHEA 
 
STILLMAN 
DIRECTOR
CARISMA THERAPEUTICS INC.   |  INNERVACE, INC.
CHIDOZIE 
 
UGWUMBA 
DIRECTOR
HUNTING HILL EQUITY ARBITRAGE FUND, LP   |  CARISMA THERAPEUTICS INC.   |  CLENE INC.   |  PLATELET BIOGENESIS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2021-01-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-12-22 
2020-07-08
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-06-26 
2019-07-09
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-06-26 
2018-07-10
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-06-26 
2018-04-17
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2017-05-31 
2017-06-14
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2017-05-31 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#